Microbiome dysbiosis in cancer: Exploring therapeutic strategies to counter the disease.

Seminars in Cancer Biology
Var Ruchi SharmaAnil K Sharma

Abstract

Cancer being a multiplex disease which involves many genomic and physiological alterations that occur consistently in the cancerous tissue, making the treatment and management of the disease even more complicated. The human gut microbiota (GM) harbors collective genomes of microbes comprising of trillions of bacteria along with fungi, archaea, and viruses that have the tendency to affect the development and progression of cancer. Moreover, inter-microbial interactions, diversity and distinct differences among the GM populations could influence the course of disease, making the microbiome an ideal target or to be modulated in such a way so as to improve cancer therapeutics with better efficacy and reduced toxicity. Current review focuses upon exploring the association of gut microbiota with the progression of cancer for which a structured search of bibliographic databases for peer-reviewed research literature has been carried out using focused review questions and inclusion/exclusion criteria. Through this review one could envisage a wide-spectrum role of microbiota in maintaining host metabolism, immune homeostasis paving the way for an anticancer diagnostic and therapeutic solution that has the potential to counter the menace ...Continue Reading

References

Apr 1, 1977·The American Journal of Digestive Diseases·M G SchmittJ J Steff
Jan 1, 1977·Annual Review of Microbiology·D C Savage
Jan 16, 2004·Gastroenterology·Jia Qing HuangRichard H Hunt
Mar 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Zhiheng PeiMartin J Blaser
May 10, 2005·The British Journal of Nutrition·Jan Van LooJohn Kevin Collins
Jun 3, 2006·Science·Steven R GillKaren E Nelson
Dec 22, 2006·Nature·Ruth E LeyJeffrey I Gordon
Jan 4, 2007·The Journal of Clinical Investigation·James G Fox, Timothy C Wang
Mar 30, 2007·Journal of Microbiological Methods·Soumitesh ChakravortyDavid Alland
May 15, 2007·The New England Journal of Medicine·Gypsyamber D'SouzaMaura L Gillison
Sep 25, 2007·International Journal of Food Microbiology·Marion BernardeauMicheline Guéguen
Oct 19, 2007·Nature·Peter J TurnbaughJeffrey I Gordon
Nov 22, 2007·The Journal of Allergy and Clinical Immunology·Mei WangSiv Ahrné
Dec 2, 2008·Nature·Peter J TurnbaughJeffrey I Gordon
Oct 13, 2009·Genome Research·UNKNOWN NIH HMP Working GroupMark Guyer
Mar 23, 2010·Research in Microbiology·Giorgio GiraffaYantyati Widyastuti
Jun 23, 2010·BMC Microbiology·Serena SchippaMaria Pia Conte
Jun 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Maria G Dominguez-BelloRob Knight
Jun 24, 2010·Proceedings of the National Academy of Sciences of the United States of America·Marcus J ClaessonPaul W O'Toole
Jan 7, 2011·The Journal of Infectious Diseases·Cynthia L Sears, Drew M Pardoll
Jan 21, 2011·Current Cancer Drug Targets·Lidija Klampfer
Mar 3, 2011·Nature Reviews. Clinical Oncology·Leroy Hood, Stephen H Friend
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
May 3, 2011·Gastroenterology·Maria Gloria Dominguez-BelloRob Knight
May 7, 2011·Journal of Oncology·Wen-Jiun LinShih-An Liu
Jul 22, 2011·Trends in Microbiology·Daniel N FrankEllen Li
Aug 31, 2011·Proceedings of the National Academy of Sciences of the United States of America·Andrew C GoodwinRobert A Casero
Sep 14, 2011·Annual Review of Pathology·Kathryn J Pflughoeft, James Versalovic
Oct 1, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Annemarie BoleijHarold Tjalsma
Oct 18, 2011·Journal of Cardiothoracic Surgery·Panagiotis ApostolouGregory Giamouzis
Oct 20, 2011·Genome Research·Mauro CastellarinRobert A Holt
Dec 14, 2011·Molecular Carcinogenesis·Cristina BosettiPaolo Boffetta
Feb 2, 2012·Archives of Medical Science : AMS·Nagwa Abdallah IsmailDina Fekry
Mar 16, 2012·Journal of Food Science·Vikas SangwanBabar Ali
May 12, 2012·The Lancet Oncology·Catherine de MartelMartyn Plummer
Jun 20, 2012·Archives of Otolaryngology--head & Neck Surgery·Mine TezalDaniel L Stoler
Jul 17, 2012·Nature·Marcus J ClaessonPaul W O'Toole
Aug 17, 2012·Nutrition Reviews·Luke K UrsellRob Knight

❮ Previous
Next ❯

Citations

May 26, 2021·NPJ Biofilms and Microbiomes·M Fata Moradali, Mary E Davey
Sep 30, 2021·Biotechnology and Applied Biochemistry·Varruchi SharmaAnil K Sharma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Anticancer Therapy
Ingrid GarajováGodefridus J Peters
European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Kagan IpciCemal Cingi
Journal of Experimental & Clinical Cancer Research : CR
Xinyi LiuLing Dong
© 2021 Meta ULC. All rights reserved